Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mieke Raap

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 6, 2025
Clinicopathological Characteristics of a Distinct Tumor Phenotype: Invasive Lobular Carcinoma With Tubular Elements in the West German Study Group ADAPTcycle TrialMartin Radner, Sandy Burmeister, Katarzyna Jóźwiak, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 17, 2017
Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2βMieke Raap, Malte Gronewold, Henriette Christgen, et al.
Cancer|August 12, 2020
Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancerMatthias Christgen, Oleg Gluz, Nadia Harbeck, et al.
Cancer Medicine|November 15, 2021
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancerIsabel Grote, Stephan Bartels, Leonie Kandt, et al.
The Journal of Clinical Investigation|July 24, 2025
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and non-respondersGuokun Zhang, Vindi Jurinovic, Stephan Bartels, et al.
The Journal of Pathology. Clinical Research|December 10, 2021
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinomaMatthias Christgen, Leonie Donata Kandt, Wiebke Antonopoulos, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 6, 2025
Clinicopathological Characteristics of a Distinct Tumor Phenotype: Invasive Lobular Carcinoma With Tubular Elements in the West German Study Group ADAPTcycle TrialMartin Radner, Sandy Burmeister, Katarzyna Jóźwiak, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 17, 2017
Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2βMieke Raap, Malte Gronewold, Henriette Christgen, et al.
Cancer|August 12, 2020
Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancerMatthias Christgen, Oleg Gluz, Nadia Harbeck, et al.
Cancer Medicine|November 15, 2021
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancerIsabel Grote, Stephan Bartels, Leonie Kandt, et al.
The Journal of Clinical Investigation|July 24, 2025
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and non-respondersGuokun Zhang, Vindi Jurinovic, Stephan Bartels, et al.
The Journal of Pathology. Clinical Research|December 10, 2021
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinomaMatthias Christgen, Leonie Donata Kandt, Wiebke Antonopoulos, et al.
Pageof 2